Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Manufacturing Woes Plague Shipment of Moderna COVID-19 Jab to South Korea

07/27/2021 | 06:12am EDT


© MT Newswires 2021
All news about MODERNA, INC.
09/18MODERNA : U.S. administers about 384.9 mln doses of COVID-19 vaccines -CDC
RE
09/18MODERNA : U.S. CDC Says Administered 384,911,290 Doses Of COVID-19 Vaccine As Of..
RE
09/17Wall Street ends rollercoaster week sharply lower
RE
09/17MODERNA : Torrid Moderna stock rally cools over booster shot doubts
RE
09/17Healthcare Shares Finish Up Slightly, Beating Broader Market -- Healthcare Ro..
DJ
09/17The case for, and against, COVID-19 vaccine boosters
RE
09/17US Stocks Drop as Large-Cap Techs Lose Luster; Consumer Sentiment Disappoints..
MT
09/17MODERNA : U.S. FDA vaccine advisers vote in favor of COVID-19 booster shot for t..
RE
09/17MODERNA : U.S. administers about 384 mln doses of COVID-19 vaccines - CDC
RE
09/17MODERNA : U.S. CDC Says Delivered 464,315,725 Doses Of Covid-19 Vaccine As Of Se..
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 348 M - -
Net income 2021 12 529 M - -
Net cash 2021 12 947 M - -
P/E ratio 2021 14,5x
Yield 2021 -
Capitalization 174 B 174 B -
EV / Sales 2021 7,89x
EV / Sales 2022 7,29x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 430,05 $
Average target price 306,23 $
Spread / Average Target -28,8%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420
PHARMARON BEIJING CO., LTD.83.56%25 755